TOKYO--(BUSINESS WIRE)--Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) ...

Gilead Sciences has broadened its partnership with Korean manufacturer Yuhan, agreeing to a 210 billion Korean won ($140 million) supply deal for active pharmaceutical ingredients (API) for an ...

Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage tablets, capsules and RNA therapeutics to its campus in Morrisville. The new ...

Reusable order-flow charts, studies, and React bindings for applications built on TradingView lightweight-charts. This package is designed for host apps that already own chart creation, market-data ...

Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...

Most hydrogenation projects begin with a familiar mandate: a promising Business Case, challenging timelines, and a facility that has to robustly & safely run multiple products under strict GMP rules.

RNA therapeutics are expanding rapidly, driving demand for manufacturing processes that can keep pace with clinical translation. Because mRNA yield and impurity profiles are jointly influenced by ...

American pharmaceutical company AbbVie has announced plans to expand manufacturing at its campus in North Chicago, Illinois. The company will invest US$380 million into advanced manufacturing ...

Active pharmaceutical ingredients (APIs) form the backbone of modern medicine, driving the efficacy and safety of countless therapeutic products. According to a recent report by MarketsandMarkets, the ...

Inke is a manufacturer of inhalation active pharmaceutical ingredients Inke is based in Barcelona, Spain Pharmanoid’s products are authorized for commercialization in more than 25 countries Inke, ...

President Trump vowed to bring factories back. Is he succeeding? By Farah Stockman Graphics by Karl Russell Farah Stockman covers manufacturing. Karl Russell visualizes economic and market data.

Cambrex is investing $120 million to expand US API manufacturing, enhancing supply chain security and resilience. The Charles City, IA site will see a 40% capacity increase, supporting reshoring of ...